<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0115">
 <label>115.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Marty</surname>
   <given-names>FM</given-names>
  </string-name>, 
  <string-name>
   <surname>Winston</surname>
   <given-names>DJ</given-names>
  </string-name>, 
  <string-name>
   <surname>Chemaly</surname>
   <given-names>RF</given-names>
  </string-name>, et al. 
  <article-title>A randomized, double-blind, placebo-controlled phase 3 trial of oral brincidofovir for cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplantation</article-title>. 
  <source>
   <italic toggle="yes">Biol Blood Marrow Transplant</italic>
  </source>. 
  <year>2019</year>;
  <volume>25</volume>(
  <issue>2</issue>):
  <fpage>369</fpage>â€“
  <lpage>381</lpage>. doi:
  <pub-id pub-id-type="doi">10.1016/j.bbmt.2018.09.038</pub-id>
  <pub-id pub-id-type="pmid">30292744</pub-id>
 </mixed-citation>
</ref>
